This report shows in stark numbers what American patients and pharmacists already feel every day – our medicine cabinet has been hollowed out, and we are now dangerously dependent on a handful of foreign, sometimes even adversarial, countries for the drugs that keep people alive.
For the first time on record, the United States makes barely a quarter of the medicine it needs.
For years, the most critical link in our drug supply chain — the upstream chemistry — has been invisible to our own regulators. A medicine finished in Europe is not necessarily a European medicine, and this rule finally begins to expose that fiction.
Sen. Kirsten Gillibrand (D-NY) has become one of the Democratic Party’s leading voices raising concerns about the pharmaceutical industry’s growing ties to China.
Lawmakers from member states of the European Union agreed to measures last week to stop drug shortages and fix chronic Asian dependencies for critical medicines, this time spurred by worries over the antibiotics supply chain.
Without secure upstream API and 6-APA production, the United States does not have true antibiotic supply security. With the right policy framework and close coordination with European partners, we can rebuild domestic capacity, strengthen allied production, and secure essential medicines for the long term.
China holds a rapidly expanding position in the global biologics and biosimilars market, driven by heavy government support, regulatory reforms, and massive investments in biotech hubs like Shanghai and Suzhou.
CPA welcomes new proposals from the Food and Drug Administration (FDA) aimed at rebuilding domestic generic drug manufacturing, strengthening oversight of foreign pharmaceutical production, and improving supply chain transparency.
Today’s action is a meaningful step toward restoring America’s ability to produce critical pharmaceuticals and APIs.
America’s healthcare system cannot remain dependent on fragile and subsidized foreign supply chains for generic pharmaceuticals and other critical countermeasures that are fundamental to patient care.
